Point-of-care testing and optimization of sample treatment for fluorometric determination of hydrogen sulphide in plasma of cardiovascular patients

心血管患者血浆中硫化氢荧光测定的即时检测和样品处理优化

阅读:9
作者:Ahmed K Alyan, Rasha S Hanafi, Mohamed Z Gad

Conclusion

The study is novel in being a POCT approach for selective determination of H2S molecular form in plasma after simple optimized sample treatment. The study confirms that MI is associated with H2S elevated levels up to 10 hours from emergence of symptoms.

Methods

Dansyl azide was synthesized to react with hydrogen sulfide in biological matrix to produce the fluorescent dansyl amide. Fluorescence was measured at λex 340 nm and λem 517 nm in the new in-house POCT portable spectrofluorometer. The method was validated according to ICH guidelines. Several blood sample treatments and reaction protocols were compared to achieve maximum fluorescence yield.

Results

The H2S Analyser was verified in comparison to a benchtop spectrofluorometer where linearity was confirmed in the range of 3-300 μM, LOD being 1 μM, at λex 340 nm and λem 517 nm. Sample treatment involving blood centrifugation followed by addition of reagent on plasma produced maximum fluorescence yield. Analysis of blood samples of myocardial infarction (MI) patients and controls showed elevated levels of H2S in MI patients (28 μM ± 1.111) vs. controls (23 μM ± 1.036) at p = 0.0015.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。